Preferred Name

Diffuse large B-cell lymphoma

ID

http://www.orpha.net/ORDO/Orphanet_544

alternative_term

DLBCL

definition

Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma (NHL; see this term) in adults characterized by a median age of presentation in the sixth decade of life (but also rarely occurring in adolescents and children) with the initial presentation being single or multiple rapidly growing masses (that may or may not be painful) in nodal or extranodal sites (such as thyroid, skin, breast, gastrointestinal tract, testes, bone, or brain) and that can be accompanied by symptoms of fever, night sweats and weight loss. DLBCL has an aggressive disease course, with the elderly having a poorer prognosis than younger patients, and with relapses being common.

definition_citation

Orphanet

expertlink

https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=544

has_age_of_onset

Adult

has_inheritance

Not applicable

Multigenic/multifactorial

hasDbXref

ICD-10:C83.3

UMLS:C0079744

MeSH:D016403

MedDRA:10012818

ICD-11:2A81

label

Diffuse large B-cell lymphoma

notation

ORPHA:544

Clinical group

prefixIRI

ORDO:Orphanet_544

prefLabel

Diffuse large B-cell lymphoma

present_in

Slovakia AND has_annual_incidence_average_value : 3.259 AND has_annual_incidence_range : 1-9 / 100 000

Switzerland AND has_annual_incidence_average_value : 6.328 AND has_annual_incidence_range : 1-9 / 100 000

Spain AND has_annual_incidence_average_value : 4.78 AND has_annual_incidence_range : 1-9 / 100 000

Malta AND has_annual_incidence_average_value : 2.827 AND has_annual_incidence_range : 1-9 / 100 000

Netherlands AND has_annual_incidence_average_value : 6.478 AND has_annual_incidence_range : 1-9 / 100 000

Bulgaria AND has_annual_incidence_average_value : 1.229 AND has_annual_incidence_range : 1-9 / 100 000

Slovenia AND has_annual_incidence_average_value : 4.773 AND has_annual_incidence_range : 1-9 / 100 000

Germany AND has_annual_incidence_average_value : 4.586 AND has_annual_incidence_range : 1-9 / 100 000

France AND has_annual_incidence_average_value : 6.5 AND has_annual_incidence_range : 1-9 / 100 000

Estonia AND has_annual_incidence_average_value : 3.815 AND has_annual_incidence_range : 1-9 / 100 000

Italy AND has_annual_incidence_average_value : 6.47 AND has_annual_incidence_range : 1-9 / 100 000

Belgium AND has_annual_incidence_average_value : 5.51 AND has_annual_incidence_range : 1-9 / 100 000

Portugal AND has_annual_incidence_average_value : 2.635 AND has_annual_incidence_range : 1-9 / 100 000

Ireland AND has_annual_incidence_average_value : 3.458 AND has_annual_incidence_range : 1-9 / 100 000

Austria AND has_annual_incidence_average_value : 2.227 AND has_annual_incidence_range : 1-9 / 100 000

Latvia AND has_annual_incidence_average_value : 0.298 AND has_annual_incidence_range : 1-9 / 1 000 000

Lithuania AND has_annual_incidence_average_value : 2.984 AND has_annual_incidence_range : 1-9 / 100 000

Norway AND has_annual_incidence_average_value : 5.115 AND has_annual_incidence_range : 1-9 / 100 000

Finland AND has_annual_incidence_average_value : 1.244 AND has_annual_incidence_range : 1-9 / 100 000

Iceland AND has_annual_incidence_average_value : 4.559 AND has_annual_incidence_range : 1-9 / 100 000

Czech Republic AND has_annual_incidence_average_value : 3.304 AND has_annual_incidence_range : 1-9 / 100 000

Croatia AND has_annual_incidence_average_value : 0.765 AND has_annual_incidence_range : 1-9 / 1 000 000

Europe AND has_annual_incidence_average_value : 2.79 AND has_annual_incidence_range : 1-9 / 100 000

United Kingdom AND has_annual_incidence_average_value : 4.931 AND has_annual_incidence_range : 1-9 / 100 000

Poland AND has_annual_incidence_average_value : 1.673 AND has_annual_incidence_range : 1-9 / 100 000

Europe AND has_point_prevalence_average_value : 43.0 AND has_point_prevalence_range : 1-5 / 10 000

subClassOf

http://www.orpha.net/ORDO/Orphanet_300846

http://www.orpha.net/ORDO/Orphanet_557492

Delete Subject Author Type Created
No notes to display